脑部放疗,上午比下午敏感许多!9 ?& J" ^' L& p6 ?/ T {
9 X4 m. }2 l9 S3 j" C. B V. M& S7 i& n
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
5 H' f8 r1 z, [ F; h! }- B2 c2 @Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
6 S$ J8 h; U% ORahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
$ i8 ~( E5 k( L9 P; {SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
3 r% f) B' j( }& x5 c+ r4 d8 k* B {( `. Q( A
Abstract
/ i$ |* R; a8 m0 n. _& t7 k# ?BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
% P5 J9 r8 `" N& ?8 G, ]$ ^' k7 T6 c8 D, J& O* b9 b- e
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
; K( |- ^" j! m7 c8 v* }2 Q' s* U# ?/ Z3 k) o; y
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( N1 I9 N0 }6 J) t b' Y/ q
( z8 {- X2 k6 h, y$ _CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.) W- n+ l& E# J9 x& i2 s1 b/ e
8 z9 R( r1 R* e/ Q; h6 W6 [
|